Oct. 20, 2011
Dehaier Medical Systems Ltd. (NASDAQ: DHRM)
("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in
, today announced that it will participate in the Medtrade Conference, to be held from
October 25-27, 2011
at the Georgia World Congress Center in
Medtrade Conference is one of the first and largest homecare medical equipment exhibitions on the East Coast. Conference attendees include wholesalers, agents, distributors, hospitals, medical health institutions and medical experts. During the conference, Dehaier will exhibit its whole portfolio of self-branded homecare medical products, including its Continuous Positive Airway Pressure (CPAPs) devices, sleep diagnostics products and nebulizers.
"The Medtrade Conference will be our first opportunity to introduce Dehaier's second generation respiratory homecare medical products and concepts to the public. The exhibit will allow us to build brand awareness for the products we design as well as broaden our distribution channels. We look forward to meeting with thousands of customers and distributors in
," said Mr.
, Dehaier's Chief Executive Officer. "We plan to continue expanding into international markets by introducing more innovative, high quality and high performance products in the future. We believe our concept of being a one stop solution provider, combined with our all around homecare medical products will bring a bright future to our development and to create long term value to our customers"
Oct 25th- 27th, 2011
Location: Georgia World Congress Center in
Booth number: 437
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products in
, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (
), Welch Allyn (
), HEYER (
), Timesco (UK), eVent Medical (US) and JMS (
). Dehaier's technology is based on five patents and five software copyrights; additionally we have three pending patents and six pending software copyrights, and proprietary technology. More information may be found at http://www.chinadhr.com.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.